News Releases

CLEVELAND – University Hospitals (UH) Case Medical Center has once again been named one of the nation's top hospitals, according to U.S. News & World Report’s annual Best Hospitals rankings. UH Case Medical Center was ranked in all 12 methodology-ranked specialties for the third year in a row and in the Top 20 in four specialties - Cancer, Gastroenterology, Ear, Nose & Throat, and Orthopaedics.
 
The recent data underscores UH Case Medical Center’s elite, national standing as a leader in clinical care as just 3 percent of the nearly 5,000 hospitals that were analyzed for Best Hospitals 2014-15 earned national ranking in even one specialty.
 
"We are extremely pleased that U.S. News & World Report has once again recognized University Hospitals Case Medical Center as one of the top academic medical centers in America," says Fred C. Rothstein, MD, President, UH Case Medical Center. “We are proud to be nationally recognized for our extraordinary commitment to quality, safety and best practices in patient care.”

CLEVELAND – The U.S. Department of Health and Human Services (HHS) has announced a three-year grant to University Hospitals (UH) Case Medical Center Seidman Cancer Center totaling $4.7 million to support a new national model aimed at improving care for patients with complex cancer.

Titled “Evidence-Conformant Oncology Care,” the project will test a unique model developed at UH to enhance care for adult cancer patients with late-stage disease, significant comorbidities, or demonstrated need for high health care utilization. 

“We believe that the best cancer care assures that patients understand their condition and recommended treatments, that patients are engaged as partners in decision making and that caregivers are attuned to the personal side of the patient as well as the medical,” said Nathan Levitan, MD, President of UH Seidman Cancer Center. 

CLEVELAND – Leaders from Case Western Reserve University and University Hospitals this evening announced a new collaborative fundraising effort focused on Adolescent and Young Adult (AYA) cancer. The news came as Char and Chuck Fowler announced their third major philanthropic commitment aimed at defeating the disease that claimed their 14-year-old daughter, Angie, in 1983.

Inspired by the new collaboration and the Fowlers’ generosity, an anonymous donor also made a $5 million contribution to support the Angie Fowler Adolescent & Young Adult Cancer Institute at University Hospitals (UH) Rainbow Babies & Children’s Hospital. 

“Even as our nation has made immense strides in improving survival rates for pediatric and adult cancer patients, we have made far too little progress for teens and young adults,” Case Western Reserve University President Barbara R. Snyder said. “Char and Chuck Fowler have helped bring unprecedented attention and resources to this critical need, and we feel privileged to build on their efforts with this new collaborative initiative.” 

Thomas F. Zenty III, chief executive officer of University Hospitals, noted that the funds for Angie’s Institute are earmarked for completion of the Institute’s 7th-floor inpatient area. The donor’s gift is anticipated to inspire an additional $5 million in support from the philanthropic community by matching dollar for dollar gifts to Angie’s Institute that range from $25,000 to $1 million.  

“These gifts will amplify UH and CWRU as national leaders in treating and curing adolescent and young adult cancers,” Zenty said. “This extraordinary philanthropic support for both research and clinical care promises to significantly advance treatments for our young cancer patients and AYA patients around the world.” 
 
The Fowlers’ $6.7 million pledge to Case Western Reserve University will support an extraordinary array of state-of-the-art research initiatives designed to develop breakthrough solutions to treat and cure AYA cancers, the leading cause of disease-related death for this age group.

CLEVELAND – 3D Mammography finds significantly more invasive cancers and reduces unnecessary recalls, according to a large, retrospective study published in the Journal of the American Medical Association (JAMA). The study features data from University Hospitals Case Medical Center Seidman Cancer Center.
 
The study, the largest of its kind, focused on the impact of 3D mammography at a diverse range of sites across the U.S, looking at nearly half a million mammograms at 13 sites.
Key Findings:

• 41percent increase in invasive cancer detected with 3D mammography
• 15 percent decrease in unnecessary recalls for false alarms
• 29 percent increase in the detection of all breast cancers

CLEVELAND – Alan Lerner, MD, and colleagues at University Hospitals (UH) Case Medical Center are conducting a Phase 3 clinical trial to evaluate the safety and effectiveness of an investigational medicine called LMTX™ in people with a type of dementia known as behavioral-variant Frontotemporal Dementia (bvFTD - previously known as Pick’s Disease).

 

LMTX™, is a tau aggregation inhibitor, which targets tau tangles that develop inside brain cells and eventually ‘strangle’ them. The destruction of these brain cells by these tau tangles results in dementia.

 

“FTD affects people at a younger age than the typical age seen in other dementias, such as Alzheimer’s disease,” said Dr. Lerner, who is Director of the Brain Health and Memory Center at UH Case Medical Center and Professor of Neurology at Case Western Reserve University School of Medicine.  “It is a devastating disease for patients and their families because it affects the front part of the brain which can change a person’s personality, behavior, language and other skills. And currently, there is no treatment for it.”